Skip to content
OpenCapital
Get started

Revolution Medicines, Inc. RVMD Increase Decrease In Other Prepaid And Noncurrent Assets

Other financials

Income statement

See full
Revenue-—
Operating income-$445.2M-84.9%
Net income-$453.8M-113%
EPS (diluted)-$2.29-103%

Balance sheet

See full
Cash & equivalents$440.9M+32.2%
Total debt$156.6M+16.6%
Total equity$1.5B-27.8%
Total assets$2.3B-4.7%

Cash flow

See full
Operating cash flow-$354.2M-82.2%
CapEx$1.5M-52.9%
Free cash flow-$355.7M-79.9%

Valuation

See full
Market cap$34.65B+193%
Enterprise value$34.37B+198%

Profitability

See full
Operating margin-88,031.9%-89,488pp
Net margin-76,423.3%-77,733pp

Returns & leverage

See full
Return on equity-76.7%-923pp
Debt / equity0.1×0.0×
Current ratio6.8×-6.7×

Where this comes from

Reported directly by Revolution Medicines, Inc. in its filing.

Tagged under the XBRL concept rvmd:IncreaseDecreaseInOtherPrepaidAndNoncurrentAssets.

The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revolution Medicines, Inc.'s increase decrease in other prepaid and noncurrent assets.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revolution Medicines, Inc.'s increase decrease in other prepaid and noncurrent assets?
Revolution Medicines, Inc. (RVMD) reported increase decrease in other prepaid and noncurrent assets of $378K in Q1 2026.